Schizoaffective Disorders Completed Phase 2 / 3 Trials for Glycine (DB00145)

Also known as: Schizoaffective disorder / Schizophrenia schizoaffective / Schizoaffective psychosis / Schizo-affective type schizophrenia

IndicationStatusPhase
DBCOND0033299 (Schizoaffective Disorders)Completed2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00222235Adjunctive Treatment for Decreasing Symptoms of SchizophreniaTreatment